Stay updated on Pembrolizumab in MPM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MPM Clinical Trial page.

Latest updates to the Pembrolizumab in MPM Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a minor update to the study record metadata without altering study content.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, signaling a small metadata update to the study record without altering substantive information.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page now indicates that recruitment has ended for participants. It adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header formatting, with the revision noted as v3.6.0.SummaryDifference0.3%

- Check46 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a minor site update. This does not modify the study content or how users interact with the page.SummaryDifference0.0%

- Check68 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4. This indicates the study record has been updated to a newer revision of the page content.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3. This reflects a platform release rather than a change to the clinical trial study content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MPM Clinical Trial page.